The current valuation score of Fulgent Genetics Inc is 9.06, ranking 26 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -8.21, which is -192.73% below the recent high of 7.61 and -484.95% above the recent low of -48.02.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.